FDA approves first immunotherapy drug for nasopharyngeal carcinoma. Nierengarten MB. Cancer 2024;130:1903.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. FDA approves first immunotherapy drug for nasopharyngeal carcinoma. Cancer 2024;130:1903.
PMID: 38757625